Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: A comparison of rocuronium and mivacurium.
Rohling RG, Rentsch KM, Beck-Schimmer B, Fuchs-Buder T
J Clin Anesth 2003;15(2):85-90.
Review by
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA, Hoffman M, Roberts HR, Monroe DM
Can J Anaesth 2002;49(10):S7-S14.
Review by Aldouri M
Blood transfusion medicine.
Regan F, Taylor C
BMJ 2002;20;325(7356):143-147.
Review by Kretschmer V
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Lawler P, White B, Pye S, et al.
Haemophilia 2002;8(2):145-148.
Review by
Potential role for rFVIIa in transfusion medicine.
Hedner U, Erhardtsen E
Transfusion 2002;42(1):114-124.
Review by Aldouri M
Influence of storage on red blood cell rheological properties.
Berezina TL, Zaets SB, Morgan C, et al.
J Surg Res 2002;102(1):6-12.
Review by V. Kretschmer
Survey of the use of whole blood in current blood transfusion practice.
MacLennan S, Murphy MF
Clin Lab Haematol 2001;23(6):391-396.
Review by
Analysis of 516 reaction reports after transfusion of blood cell components.
Frere MC, Rapaille A, Bouillenne C, Gerard C, Sondag D, Verhees A
Transfus Clin Biol 2001;8(4):333-342.
Review by Kretschmer V.
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659